2004
DOI: 10.1186/1477-5751-3-5
|View full text |Cite
|
Sign up to set email alerts
|

CP-31398, a putative p53-stabilizing molecule tested in mammalian cells and in yeast for its effects on p53 transcriptional activity

Abstract: BackgroundCP-31398 is a small molecule that has been reported to stabilize the DNA-binding core domain of the human tumor suppressor protein p53 in vitro. The compound was also reported to function as a potential anti-cancer drug by rescuing the DNA-binding activity and, consequently, the transcription activation function of mutant p53 protein in mammalian tissue culture cells and in mice.ResultsWe performed a series of gene expression experiments to test the activity of CP-31398 in yeast and in human cell cul… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
19
0
1

Year Published

2005
2005
2017
2017

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 27 publications
(20 citation statements)
references
References 27 publications
0
19
0
1
Order By: Relevance
“…Recently, pharmacogenomic approaches have also been proposed, with the use of synthetic compounds able to bind specifically to the DBD of the p53 mutants and to restore their proper protein configuration, and, thus, allow DNA binding (Bykov et al 2002, Tanner & Barberis 2004). These small synthetic compounds could be used in combination with traditional chemotherapy to sensitize poorly differentiated thyroid cancer cells to the cytotoxic effect of these agents.…”
Section: Possible Role Of P53 Family Proteins In Gene Therapymentioning
confidence: 99%
“…Recently, pharmacogenomic approaches have also been proposed, with the use of synthetic compounds able to bind specifically to the DBD of the p53 mutants and to restore their proper protein configuration, and, thus, allow DNA binding (Bykov et al 2002, Tanner & Barberis 2004). These small synthetic compounds could be used in combination with traditional chemotherapy to sensitize poorly differentiated thyroid cancer cells to the cytotoxic effect of these agents.…”
Section: Possible Role Of P53 Family Proteins In Gene Therapymentioning
confidence: 99%
“…Those molecules are targeted against wild-type p53 core domain and should bind generically to most mutants. Other molecules have been proposed to stabilize the folded state of the core domain of p53 [e.g., CP-31398 (12)], but, unlike the aforementioned examples, do not bind reversibly to the core domain (10,13,14) and promote anticancer effects in vivo via routes other than thermal stabilization of p53 (15).…”
mentioning
confidence: 99%
“…Cancer 41 We hypothesized that intercalation of DNA by acridine derivatives may activate a unique p53 response, which is different from DNA damage induced by ionizing radiation, UV light exposure, or DNA-damaging agents. Activation of p53 led to cell death in acridine drug-exposed cells.…”
mentioning
confidence: 99%